| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/18/2005 | US6844189 Chromosome 17P-linked prostate cancer susceptibility gene |
| 01/18/2005 | US6844181 Method of inhibiting fungal growth |
| 01/18/2005 | US6844179 Protein and DNA thereof |
| 01/18/2005 | US6844177 Nucleotide sequences coding preferential polypeptide for use in the diagnosis, treatment and prevention of cell proliferative defects |
| 01/18/2005 | US6844171 Oligomerization of hepatitis delta antigen |
| 01/18/2005 | US6844170 Compries nucleotide sequences coding cytokine receptor common gamma chain like proteins (CRCGCL) for diagnosis and treatment autoimmune disorders |
| 01/18/2005 | US6844169 Producing transgenic eschericheria as bioreator for controlling expression of heterologous proteins within trytpphan operon |
| 01/18/2005 | US6844168 Compositions comprising polynucleotides encoding human fibroblast growth factor receptor and uses thereof |
| 01/18/2005 | US6844162 Identifying imunoglobulins associated with thyroid stimulating hormone receptor (TRAB) for diagnosing and treating graves' and glandular disorders |
| 01/18/2005 | US6844161 Modular protein libraries and methods of preparation |
| 01/18/2005 | US6844160 Nucleotide sequences for detection of Bacillus anthracis |
| 01/18/2005 | US6844148 Alzheimer's disease secretase, APP substrates therefor, and uses therefor |
| 01/18/2005 | US6844000 A purified Parapoxvirus ovis envelope protein termed "B2L" can be used as a monotherapeutic agent. B2L protein also can be used in screening methods to identify potential therapeutic agents for modulating a subject's immune response |
| 01/18/2005 | US6843999 Streptococcal ABC transporter protein |
| 01/18/2005 | US6843997 Variant varicella-zoster viruses and methods of use |
| 01/18/2005 | US6843996 Immunogenic composition comprising an influenza virus with a temperature sensitive PB2 mutation |
| 01/18/2005 | US6843992 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 01/18/2005 | US6843991 Use of the M3 protein of MHV68 to block binding of a chemokine to its receptor |
| 01/18/2005 | US6843988 Synferon |
| 01/18/2005 | US6843987 Contacting pure or recombinant mammalian (interleukin)IL- 1 delta or IL-L1 epsilon with a receptor comprising the IL-1R6 receptor subunit; or mammalian IL-1 delta or IL-1 epsilon with a receptor to form complex |
| 01/18/2005 | CA2333686C Method and device for electrochemical immunoassay of multiple analytes |
| 01/18/2005 | CA2269638C Ice inhibiting peptides |
| 01/18/2005 | CA2169603C Retrovirus from the hiv group and its use |
| 01/18/2005 | CA2074556C Immunological detection method |
| 01/14/2005 | CA2454540A1 Method for inducing hepatitis c virus (hcv) replication in vitro, cells and cell lines enabling robust hcv replication and kit thereof |
| 01/14/2005 | CA2436104A1 Method for inducing hepatitis c virus (hcv) replication in vitro, cells and cell lines enabling robust hcv replication and kit therefor |
| 01/13/2005 | WO2005003786A2 Human g protein-coupled receptor and modulators thereof for the treatment of cardiovascular disorders |
| 01/13/2005 | WO2005003782A1 Secreted polypeptide species reduced in cardiovascular disorders |
| 01/13/2005 | WO2005003776A2 In vitro methods for detecting renal cancer |
| 01/13/2005 | WO2005003720A2 Method of detecting the cystic fibrosis transmembrane conductance regulator (cftr) at cell exterior |
| 01/13/2005 | WO2005003372A2 Mylks as modifiers of branching morphogenesis and methods of use |
| 01/13/2005 | WO2005003353A1 Genetically modified brucella cells and pharmaceutical composition containing these cells |
| 01/13/2005 | WO2005003351A1 Differential expression of nucleic acid molecules |
| 01/13/2005 | WO2005003349A1 Rice transposon gene |
| 01/13/2005 | WO2005003330A2 Acapsular p. multocida hyae deletion mutants |
| 01/13/2005 | WO2005003326A2 Artificial receptors including reversibly immobilized building blocks and methods |
| 01/13/2005 | WO2005003316A2 Rna processing protein complexes and uses thereof |
| 01/13/2005 | WO2005003315A2 Compositions and methods for peptide-assisted transfection |
| 01/13/2005 | WO2005003313A2 Methods and compositions for enhanced protein expression and purification |
| 01/13/2005 | WO2005003303A2 Nadks as modifiers of branching morphogenesis and methods of use |
| 01/13/2005 | WO2005003299A2 Polynucleotides encoding novel guanylate binding proteins (gbp's) |
| 01/13/2005 | WO2005003297A2 Mptens as modifiers of the pten/igf pathway and methods of use |
| 01/13/2005 | WO2005003296A2 Albumin fusion proteins |
| 01/13/2005 | WO2005003292A2 Composition and method for self-assembly and mineralization of peptide amphiphiles |
| 01/13/2005 | WO2005003177A2 Molecules for the targeting and the in situ assembly of therapeutic proteins and use thereof |
| 01/13/2005 | WO2005003167A1 Ubiquitinated tnf receptor 2 and its uses |
| 01/13/2005 | WO2005003166A1 Fluorescein-labelled peptides |
| 01/13/2005 | WO2005003165A2 Cytokine variant polypeptides |
| 01/13/2005 | WO2005003162A2 An endogenous peptide and active subfragments thereof |
| 01/13/2005 | WO2005003161A2 Human secreted proteins |
| 01/13/2005 | WO2005003160A1 Actin mutants |
| 01/13/2005 | WO2005003159A1 Complement depletion using recombinant human c3-derivatives |
| 01/13/2005 | WO2005003158A2 Compositions and methods for increasing bone mineralization |
| 01/13/2005 | WO2005003157A2 Interferon variants with improved properties |
| 01/13/2005 | WO2005003156A1 Polypeptides having binding affinity for her2 |
| 01/13/2005 | WO2005003155A1 Protein achieving improved blocking efficiency |
| 01/13/2005 | WO2005003154A2 Compositions and methods for the diagnosis and treatment of tumor |
| 01/13/2005 | WO2005002628A1 Increased t-cell tumor infiltration by mutant light |
| 01/13/2005 | WO2005002614A1 Methods and compositions for treating disorders of the extracellular matrix |
| 01/13/2005 | WO2005002526A2 Method and compositions for treatment of viral infections |
| 01/13/2005 | WO2005002516A2 Leukocyte internalized peptide-drug conjugates |
| 01/13/2005 | WO2005002501A2 Novel druggable regions in the dengue virus envelope glycoprotein and methods of using the same |
| 01/13/2005 | WO2005002500A2 Inhibitors of coronavirus |
| 01/13/2005 | WO2005002417A2 Cancer -linked gene aas target for chemotherapy |
| 01/13/2005 | WO2005002325A2 Generation of plants with improved drought tolerance |
| 01/13/2005 | WO2004099422A3 Adenovirus particles with enhanced infectivity of dendritic cells and particles with decreased infectivity of hepatocytes |
| 01/13/2005 | WO2004094639A3 Recombinant fel d 1 allergen |
| 01/13/2005 | WO2004086039A3 A method for modulating nod1 activity, use of a mtp related molecule for modulating nod1 activity, and therapeutic applications thereof |
| 01/13/2005 | WO2004085644A3 Method for producing recombinant organisms |
| 01/13/2005 | WO2004082567A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d1a (drd1) |
| 01/13/2005 | WO2004080375A3 Vaccine therapy of atherosclerosis |
| 01/13/2005 | WO2004078983A3 Enhanced amylose production in plants |
| 01/13/2005 | WO2004074321A3 Therapeutic gpcr targets in cancer |
| 01/13/2005 | WO2004069876A3 Trimeric polypeptide construct to induce an enduring t cell response |
| 01/13/2005 | WO2004069191A3 Identification of t1r and t2r modulators |
| 01/13/2005 | WO2004069136A3 Mucin-like polypeptides |
| 01/13/2005 | WO2004063378A3 Polypeptides involved in floral development and genes encoding the same |
| 01/13/2005 | WO2004056860A3 Chorionic somatomammotropin hormone splice variants |
| 01/13/2005 | WO2004054351A3 Generation of plants with altered oil content |
| 01/13/2005 | WO2004050017A3 Rationally designed antibodies |
| 01/13/2005 | WO2004044170A3 A pancreatic islet transcription factor and uses thereof |
| 01/13/2005 | WO2004043141A3 Novel inhibin-related multiple antigenic peptide compositions that enhance production performance in avians |
| 01/13/2005 | WO2004041779A3 Amyloid plaque formation by glycosaminoglycans |
| 01/13/2005 | WO2004031230A3 Novel mhc ii associated peptides |
| 01/13/2005 | WO2004024097A8 Compositions and methods for the treatment of immune related diseases |
| 01/13/2005 | WO2003104273A9 Therapeutic epitopes and uses thereof |
| 01/13/2005 | WO2003102592A3 Selective binding and analysis of macromolecules: quantitative analysis of proteins in complex mixtures |
| 01/13/2005 | WO2003074073A3 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 01/13/2005 | WO2003072715A8 Gasp1: a follistatin domain containing protein |
| 01/13/2005 | WO2003048341A3 Cap-gly domain structure and uses thereof |
| 01/13/2005 | WO2003017943A3 Therapeutic compositions and methods for treating viral infection |
| 01/13/2005 | WO2003008540A8 Abiotic stress responsive polynucleotides and polypeptides |
| 01/13/2005 | WO2002092001A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 01/13/2005 | WO2002061049A3 Novel molecules of the pyrin/nbs/lrr protein family and uses thereof |
| 01/13/2005 | US20050010975 expression vector comprising nucleotide sequences coding retinoblastoma protein-3 (RB-3) for use in identifying modulators which shall enhances maize growth and crop yield |
| 01/13/2005 | US20050010974 Promoters for regulation of gene expression in plant roots |
| 01/13/2005 | US20050010973 Expression vector comprising heterologous nucleotide sequences which enhance amino acid biosynthesis in plants; bioreactor; tissue engineering; for use in enhancing nutritional content of animal feeds |
| 01/13/2005 | US20050010967 Animal model comprising nucleotide sequences coding small conductance calcium-activated potassium (SK) channel protein for use in identifying modulators for treatment of behavioral disorders and nervous system disorders |
| 01/13/2005 | US20050010043 Recombinant flavivirus for use in generation of vaccines to prevent and treat hemorrhagic fever |
| 01/13/2005 | US20050010042 Expression vector comprising nucleotide sequences comprising pro-polypeptide for use in the diagnosis, prevention and treatment of cell proliferative, inflammatory, cardiovascuar and nervous system disorders |